NCT03372720View on ClinicalTrials.gov

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

December 18, 2019

Study Completion Date

April 12, 2022

Conditions
Cervical CarcinomaDyspareuniaEndometrial CarcinomaOvarian CarcinomaVaginal CarcinomaVaginal DrynessVulvar Carcinoma
Interventions
PROCEDURE

Laser Therapy

Undergo fractional CO2 laser therapy

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Sham Intervention

Undergo sham laser therapy

Trial Locations (4)

21287

Johns Hopkins University, Baltimore

43210

Ohio State University Comprehensive Cancer Center, Columbus

55905

Mayo Clinic, Rochester

58104

Sanford Roger Maris Cancer Center, Fargo

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT03372720 - Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | Biotech Hunter | Biotech Hunter